Concepedia

Kenji P. Fujita

KP

Statistics

Publications

19

Citations

2.1K

H-Index

17

Active since

2003

Affiliations

Alexion Pharmaceuticals (United States)(Current)

University of North Carolina at Chapel Hill

Merck & Co., Inc., Rahway, NJ, USA (United States)

Shriners Hospitals for Children - Erie

Barnes-Jewish Hospital

Kenji P. Fujita is an author at Alexion Pharmaceuticals (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Publications per year

2003–2024

19

Publications

19

Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder

Sean J. Pittock, Achim Berthele, Kazuo Fujihara et al. · New England Journal of Medicine · 2019 · 846 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis

Srikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar et al. · Muscle & Nerve · 2019 · 247 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Asfotase alfa therapy for children with hypophosphatasia

Michael P. Whyte, Katherine L. Madson, Dawn Phillips et al. · JCI Insight · 2016 · 172 citations · Full text

Medicine, Molecular Medicine, Bone Metabolism +15

Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial

Michael P. Whyte, Jill H. Simmons, Scott Moseley et al. · The Lancet Diabetes & Endocrinology · 2018 · 145 citations

Medicine, Child Health, Pediatrics +4

‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

John Vissing, Saiju Jacob, Kenji P. Fujita et al. · Journal of Neurology · 2020 · 97 citations · Full text

Nursing, Neurology, Pharmacotherapy +17

1–5 of 19